PT-141 is a synthetic cyclic heptapeptide: an acetylated norleucine followed by a ring of Asp, His, D-Phe, Arg, Trp and Lys, with a C-terminal free acid. A lactam bridge between Asp and Lys closes the ring and constrains its shape. We supply it as a 10mg vial of lyophilized powder for in vitro laboratory research.
Product Details
- Compound: PT-141
- CAS: 189691-06-3
- Molecular Weight: 1025.2 Da
- Molecular Formula: C50H68N14O10
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Structure: Cyclic heptapeptide with lactam bridge between Asp and Lys
- Purity: 99.83% HPLC purity (ILS Laboratories, batch PP2605-034)
- Form: Lyophilized powder
- Size: 10mg
- Storage: -20°C desiccated
- Testing: View COA (Verified by ILS Laboratories) →
Lab reports
The current batch report appears on this page, with a link to verify it on ILS Laboratories’ own portal. Every PT-141 report published so far is kept on one page.
- PT-141 lab report page
- Quality & testing: how we test
Common questions
What size is PT-141 sold in?
One 10mg vial per unit. Pack pricing applies automatically in the cart for orders of more than one vial.
How is it supplied?
As lyophilized (freeze-dried) powder in a sealed vial.
How fast does it ship?
Orders ship from the US within 1–2 business days, and orders of $50 or more ship free.
Is it for human use?
No. PT-141 is sold for in vitro laboratory research only. It is not for human or veterinary use, and we give no guidance on use in people or animals.





